Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.
about
Circulating tumor cells in breast cancerClinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionPrognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolationA novel approach for next-generation sequencing of circulating tumor cellsA FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolationCan circulating tumor cells predict resistance in metastatic breast cancer?Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas.Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?Clinical and biological significance of circulating tumor cells in cancer.Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvementCirculating tumor cells in breast cancer: applications in personalized medicine.The promise of circulating tumor cells for precision cancer therapy.Characterization of single circulating tumor cells.Circulating Tumor Cells as Cancer Biomarkers in the Clinic.Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance.Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining.Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms.Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.Improving the CellSearch® system.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
P2860
Q26774808-1BC6B97B-FB54-40DC-BC73-6B6FA0BE0EA8Q26827936-6CEA48FA-208C-41AC-8426-2A20CCD4001EQ28066285-AE9E7C8B-71EB-4251-8BA4-D8E9FF139F15Q33639397-FD0DE48C-0F73-443D-9806-DC2F0F4C2DD9Q35427994-46CE12C2-D1C5-42F5-BC2D-2A0E85CD4CA3Q35538013-9C349DA2-5B7A-4331-B54F-620A47044955Q36088952-C63369D7-8604-4B0E-B1AC-2CE56547082FQ36206190-B5E8CFBC-3943-4586-8B57-8323BBE3838EQ36412528-B239282F-9786-4374-A163-9428520CCF30Q36865613-A1452306-4A1C-44FB-99A0-A2C964938B33Q37352090-2727B694-8EA4-4C9B-BE85-10E1A8AAEF1CQ38697494-46AA262F-A5BC-4E85-8B58-6A0D3DA3520BQ38743200-4C48F7B2-67D4-4AFC-9307-7078415B7853Q38842969-6274C537-6A2C-4AE0-84B5-DD0C00B2F3B5Q38985771-E9B70C02-A109-42B7-89DC-75B7BC870C01Q39031157-21B6BEC5-55FB-4C1F-BDC2-150CAB456F58Q39275082-78C9D029-ED3F-4F7D-ADD2-6F7BBE62C594Q39339875-438AA0B4-6A10-4422-AF39-83C5BBB0FA53Q39767266-820BFFBF-21F3-41D2-A940-E9E6CC9D2CFBQ41128516-4FEF3B58-390C-4EDF-B202-95C92AE93DF8Q41233528-22C2471F-6055-4F26-BD47-491B1E5109A5Q47682423-2918D826-A9D8-4F6E-8A59-E0FF01839E35Q50642054-799FF0A0-6CD8-4BCC-9016-6FA16324F912Q51115531-94F0E36D-9188-4632-820C-3ED65F3ECEACQ58695249-6848A008-F565-48B0-A668-D165EDBFB01D
P2860
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Development of circulating tum ...... ceptor-positive breast cancer.
@ast
Development of circulating tum ...... ceptor-positive breast cancer.
@en
type
label
Development of circulating tum ...... ceptor-positive breast cancer.
@ast
Development of circulating tum ...... ceptor-positive breast cancer.
@en
prefLabel
Development of circulating tum ...... ceptor-positive breast cancer.
@ast
Development of circulating tum ...... ceptor-positive breast cancer.
@en
P2093
P2860
P1476
Development of circulating tum ...... eceptor-positive breast cancer
@en
P2093
Anne F Schott
Dafydd G Thomas
Daniel F Hayes
David A Chianese
Dorothy L Blossom
James M Rae
Kent A Griffith
Kimberly Aung
M Craig Miller
Maria C Muñiz
P2860
P304
P356
10.1158/1078-0432.CCR-14-1913
P407
P577
2014-11-07T00:00:00Z